Laboratori 2021/2022 - Immunologia e Oncologia di Base e Applicate

Di seguito è possibile visionare l’elenco dei Directors of Studies (e i link ai rispettivi CV) e i progetti presentati per l' a.a. 2021/2022 all'interno del curriculum in Immunologia e Oncologia di Base e Applicate

1 BORSA A PROGETTO:

Borsa a progetto BAIO1: IANNACONE MATTEO 

Unit: Dynamics of Immune Responses

BAIO1: Study the dynamics of HBsAg-specific B cells in mouse model of HBV pathogenesis

AGRESTI ALESSANDRA

Unit: In Vivo Chromatin and Transcription

Nucleosome count, genome plasticity and Epithelial-to-Mesenchymal-Transition (EMT) in cancer

BELLONE MATTEO

Unit: Cellular Immunology

Understanding the role of cytokines of the IL-17 family in multiple myeloma progression

BIANCHI MARCO 

Unit: Chromatin Dynamics

CXCR4-mediated antitumor immunization

BOLETTA ALESSANDRA

Unit: Molecular Basis of Cystic Kidney Disorders

Loss of genome repair mechanisms in the initiation and progression of renal cell carcinomas

CASUCCI MONICA

Unit: Innovative Immunotherapies

Identification of a novel CAR specificity to tackle solid malignancies

CENCI SIMONE

Unit: Age Related Diseases

Characterizing and targeting unprecedented mitochondrial vulnerabilities against multiple myeloma

CIRILLO DANIELA MARIA

Unit: Emerging Bacterial Pathogens

The role of the immune response in the pathogenesis of Non-Tubercular Mycobacteria Lung infection

DE CURTIS IVAN

Unit: Cell Adhesion

Mechanisms of regulation of a molecular network promoting cell invasion

DELLABONA PAOLO

Unit: Experimental Immunology

Adoptive immunotherapy of hepatic colorectal cancer metastasis with functionally engineered innate-like T cells

FOUSTERI GEORGIA

Unit: Regulation of Adaptive Immunity

Project 1: Role of follicular helper T cells in the humoral immune alterations in patients with mutations in the Wiskott Aldrich Syndrome protein before and after hematopoietic stem cell transplantation or gene therapy Project 2: Immune therapy with genetically engineered regulatory T cells to establish tolerance in type 1 diabetes

GHIA PAOLO

Division: Experimental Oncology-B-cell Neoplasia

Project 1: Unravelling genetic intratumor B lymphocyte heterogeneity of chronic lymphocytic leukemia Project 2:Deciphering the the role of EGR2 mutations in Chronic Lymphocytic Leukemia

GREGORI SILVIA

Unit: Mechanisms of Peripheral Tolerance

Unraveling molecular mechanisms controlling dendritic cell (DC)-mediated tolerance

KUKA MIRELA

Unit: Dynamics of Immune Responses

In depth characterization of monocyte-B cell interactions in infection and cancer

MANFREDI ANGELO

Unit: Autoimmunity and Vascular Inflammation

Mitochondrial DAMPs in vascular inflammation

MONDINO ANNA

Unit: Lymphocyte Activation

Unlocking tumors to TCR/CAR engineered T cells

MUZIO MARTA

Unit: Cell Signaling

Project 1: Exploring NFKBIZ-centered pathways in normal and malignant B-cells Project 2: Dissecting and targeting NFAT signaling in chronic lymphocytic leukemia

OSTUNI RENATO

Unit: Genomics of the innate immune system

Spatial diversity of tumor-associated macrophages

POLI GUIDO

Unit: Viral Pathogenesis and Biosafety

Project 1: Role of M1/M2 Polarization of Human Macrophages in Pathogenic RNA Virus Infection Project 2: Immuno-Virological Dynamics Triggered by Anti-HIV Therapy Suspension

SCIELZO CRISTINA 

Unit: Malignant B cells Biology and 3D modelling

Developing a comprehensive in vitro model to recapitulate the leukemic microenvironment by the use new 3D culture models.

SESSA ALESSANDRO

Unit: Stem Cells & Neurogenesis

Generation and validation of artificial epigenetic silencers to reduce brain metastases

SITIA ROBERTO

Unit: Protein Transport and Secretion, DGCB

Transmission of redox signals across compartments

TACCHETTI CARLO

Unit: CIS_Experimental Imaging Center

Translation rewiring determines triple-negative breast cancer aggressiveness: unraveling its role in metabolism and immune niche composition

TONON GIOVANNI

Unit: Functional Genomics of Cancer

Project 1: Single-cell genomic approaches to unravel cancer resistance Project 2: Unraveling how bacteria strategies are exploited by cancer cells to survive therapy

VAGO LUCA

Unit: Immunogenetics, Leukemia Genomics and Immunobiology

Identifying new actionable epigenetic drivers of leukemia immune escape

VAGO RICCARDO

Unit: Extracellular vesicles and toxins

Analysis of long non-coding RNA altered in cancer progression

VENEREAU EMILIE

Unit: Tissue Regeneration & Homeostasis

Exploring HMGB1-directed strategies to fight cancer

VICENZI ELISA

Unit: Viral Pathogens and Biosafety

SARS-CoV-2 and COVID-19: drug repurposing and viral evolution

Questo sito utilizza cookie tecnici per consentire una corretta navigazione. Clicca sul pulsante CONFERMA per accettarne il suo utilizzo. Per saperne di più leggi la nostra informativa.

CONFERMA